Type 1 Tyrosinemia (HT1) is a rare genetic disorder stemming from mutations in the tyrosine catabolism enzyme fumarylacetoacetate hydrolase (FAH), for which there exists no available cure(Russo et al., 2001). This evidence concerns the gene FAH and hereditary disease.